Cancer affects almost every Canadian family, but advances in robotics and artificial intelligence are reshaping how we diagnose and treat this disease. In this episode of Where Next Happens, Dr. Claudia Krywiak speaks with Saumik Biswas, CEO and co-founder of Tenomix, to explore the company’s journey from early innovation to commercialization of a revolutionary robotic device that accelerates and standardizes cancer diagnostics. Biswas shares his personal inspiration, the hurdles of MedTech entrepreneurship, and the promise of AI-powered tools in transforming pathology and patient care.
About Saumik Biswas
Saumik Biswas is the CEO and co-founder of Tenomix, a medical technology company transforming cancer pathology. With a PhD in Pathology and Laboratory Medicine from Western University, Saumik developed a robotic scanning device that improves lymph node detection in colon cancer tissue—helping doctors more accurately stage cancer and guide treatment. Named one of Business London’s “Twenty in their 20s,” he brings the unique perspective of a scientist turned entrepreneur, bridging research and commercialization to improve patient care.
Resources Mentioned
Ontario Centre of Innovation: https://www.oc-innovation.ca/
Tenomix: https://www.tenomix.com/
Enjoyed this Episode?
If you did, be sure to subscribe and share it with your friends! Where Next Happens is a podcast that explores bold ideas, breakthrough research, and entrepreneurial journeys shaping Ontario’s future. Post a review and share it!
If you enjoyed this episode, please leave us a review. Share it with friends and colleagues. Let's inspire everyone to innovate!
Find out more about the Ontario Centre of Innovation at https://www.https://www.oc-innovation.ca/
Thank you for tuning in!